Reply to the letter to the editor

DOI: 10.4244/EIJ-D-24-00025

Reply: Cardiovascular outcomes after 2-stent or stepwise provisional techniques for coronary bifurcation lesions

Kamil Bujak1,2, MD, PhD; Salvatore Brugaletta1, MD, PhD

We thank Güner et al1 for their interest in our paper2 and important comments. The authors of the letter expressed some concerns regarding the heterogeneity of patients’ bifurcation lesion complexity, interventional approaches, and background medical treatment in the trials included in our meta-analysis, and we thank them for the opportunity to clarify our analysis.

We strongly agree that proximal optimisation technique (POT) is an essential step in coronary bifurcation lesion treatment, recommended by the European Bifurcation Club (EBC) in case of either a provisional stenting strategy or an upfront 2-stent technique34. Although POT was introduced in the late 2000s5 and has since become a gold standard of bifurcation lesion treatment, it was not obligatory according to the protocols of the majority of randomised controlled trials (RCTs) included in our meta-analysis2. Therefore, we performed a sensitivity analysis including only those trials requiring POT. The results of this sensitivity analysis, presented in the supplementary materials of our paper, were completely consistent with the primary analysis.

The antiplatelet treatment regimen may indeed affect the outcomes of patients undergoing percutaneous...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 20 Number 7
Apr 1, 2024
Volume 20 Number 7
View full issue


Key metrics

On the same subject

10.4244/EIJV15I17A269 Apr 17, 2020
Major infections after bypass surgery and stenting: an overlooked but fatal complication
Harari R and Bangalore S
free

10.4244/EIJV14I4A69 Jul 20, 2018
What is new in the armamentarium of coronary surgeons to compete with PCI?
Gaudino M and Taggart D
free

10.4244/EIJV16I12A174 Dec 18, 2020
Translating the findings of ISCHEMIA into clinical practice: a challenging START
Boden W and Bhatt D
free

Clinical research

10.4244/EIJ-D-19-00208 Apr 17, 2020
Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial
Mancone M et al
free
Trending articles
339.13

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
312.48

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
295.45

Expert consensus

10.4244/EIJ-D-21-00898 Sep 20, 2022
Intravascular ultrasound guidance for lower extremity arterial and venous interventions
Secemsky E et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
149.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved